Related Experiment Videos
Genetic and environmental determinants of plasma lipoproteins relevant to coronary heart disease
British Journal of Clinical Practice. Supplement
|December 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections.
Infectious diseases and therapy·2022
Ibrexafungerp: A novel oral glucan synthase inhibitor.
Medical mycology·2019
Dyslipidaemia and the military patient.
Journal of the Royal Army Medical Corps·2015
Disseminated Burkholderia gladioli infection in a lung transplant recipient with underlying hypocomplementemic urticarial vasculitis.
Transplant infectious disease : an official journal of the Transplantation Society·2011
Treatment of dyslipidaemias with fluvastatin.
British journal of clinical practice. Supplement·2009
Lipoprotein(a) as a marker for coronary heart disease.
British journal of clinical practice. Supplement·2009
Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
British journal of clinical practice. Supplement·2009
Risk factor management: the cardiologist's perspective.
British journal of clinical practice. Supplement·2009
Fluvastatin in combination with other lipid-lowering agents.
British journal of clinical practice. Supplement·2009
The patient at risk: who should we be treating?
British journal of clinical practice. Supplement·2009
The "mobile bricks" of human evolution: how transposable elements shaped human phenotypes.
Frontiers in genetics·2026
Association of Serum GDF-15 with Bone and Muscle Parameters in Community-Dwelling Individuals.
Frontiers in medicine·2026
GNAI2 activating variants and MAGIS syndrome: long-term endocrine and growth outcome.
Hormones (Athens, Greece)·2026